Bracy Analytics has collaborated on many studies and take great pride in our research efforts. | ||
|
Featured Publication Using simulation to assess the sensitivity and specificity of a signal detection tool for multidimensional public health surveillance data 1Centers for Disease Control and Prevention (CDC), Epidemiology Program Office, Division of Public Health Surveillance and Informatics, E-mail: Henry Rolka (hrolka@cdc.gov) To establish the sensitivity, signals were defined based on recognized public health issues of interest (such as the introduction of a new vaccine into the population). Methods of representing a signal included a simple pair-wise association consisting of a new vaccine and one AE term, as well as a more realistic complex of multiple AE terms comprising a (p 551-562) Statistics in Medicine 2005 Feb 28;24(4). • Vesole DH, Tricot G, Jagannath S, Desikan KR, Siegel D, Bracy D, Miller L, Cheson B, Crowley J, and Barlogie B. Autotransplants in multiple myeloma: what have we learned? Blood 88: 838-847. • Tricot G, Barlogie B, Jagannath S, Bracy D, Mattox S, Vesole DH, Naucke S, and Sawyer JR. Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. Blood 86: 4250-4256.
• Tricot G, Alberts DS, Johnson C, Roe DJ, Dorr RT, Bracy D, Vesole DH, Jagannath S, Meyers R, Barlogie B. Safety of autotransplants with high-dose melphalan in renal failure: a pharmacokinetic and toxicity study. Clinical Cancer Res. 1996 Jun;2(6):947-52. • Barlogie B, Jagannath S, Naucke S, Mattox S, Bracy D, Crowley J, Tricot G, Alexanian R. Long-term follow-up after high-dose therapy for high-risk multiple myeloma. Bone Marrow Transplant. 1998 Jun;21(11):1101-7. • Desikan KR, Jagannath S, Siegel D, Nelson J, Bracy D, Barlogie B, Tricot G. Collection of more hematopoietic progenitor cells with large volume leukapheresis in patients with multiple myeloma. Leukemia & Lymphoma. 1998 Feb;28(5-6):501-8. • Jagannath S, Vesole DH, Zhang M, Desikan KR, Copeland N, Jagannath M, Bracy D, Jones R, Crowley J, Tricot G, Barlogie B. Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma. Bone Marrow Transplant. 1997 Sep;20(6):445-50. • Guba SC, Vesole DH, Jagannath S, Bracy D, Barlogie B, Tricot G. Peripheral stem cell mobilization and engraftment in patients over age 60. Bone marrow Transplant. 1997 Jul;20(1):1-3. • Tricot G, Jagannath S, Vesole DH, Bracy D, Desikan KR, Siegel D, Barlogie B. Hematopoietic stem cell transplants for multiple myeloma. Leukemia & Lymphoma;1996 Jun: 22(1-2):25-36. • Zent CS, Wilson CS, Tricot G, Jagannath S, Siegel D, Desikan KR, Munshi N, Bracy D, Barlogie B, and Butch AW. Oligoclonal Protein Bands and Ig Isotype Switching in Multiple Myeloma Treated With High-Dose Therapy and Hematopoietic Cell Transplantation. Blood 91: 3518-3523. • Barlogie B, Jagannath S, Vesole DH, Naucke S, Cheson b, Mattox S, Bracy D, Salmon S, Jacobson J, Crowley J, and Tricot G. Superiority of Tandem Autologous Transplantation over Standard Therapy for Previously Untreated Multiple Myeloma. Blood 89: 789-793. |
Bracy Analytics Incorporated 3055 Wayward Drive Marietta, Georgia 30066 Telephone: (770) 509-8994 Fax: (770) 509-8442 Email: info@bracy-analytics.com |
|